Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-13

Clinical Trial Update: TXA Nebulization for the Treatment of Hemoptysis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for tranexamic acid nebulization as a treatment for hemoptysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TXA Nebulization (tranexamic acid nebulization)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Hemoptysis | Phase 3 | Status: UNKNOWN